Introducing 

Prezi AI.

Your new presentation assistant.

Refine, enhance, and tailor your content, source relevant images, and edit visuals quicker than ever before.

Loading…
Transcript

Colorectal Cancer

Thomas Badenoch

Learning Objectives

Objectives

  • Define
  • Describe Epidemiology
  • Understand Aetiology
  • List Clinical Features
  • Principles of Investigation and Management
  • Questions

Definition

  • Cancer colon and rectum
  • 50% recto-sigmoid region
  • Older patients more proximal

Definition

Adenocarcinoma

  • Derived from epithelial gland cells
  • 95-98% of all Colorectal cancer
  • Subtypes- Mucinous (10-15%), Signet Ring Cell(1%)

Adenocarcinoma

Rare Types

  • Neuroendocrine Tumours (Carcinoid)
  • 1% Total
  • More common in small bowel

  • Lymphoma
  • Non-Hodgkin lymphoma
  • 5% of all Lymphomas
  • Men>Women

  • Gastro-Intestinal Stromal Tumours (GIST)
  • Rare
  • Form of Sarcoma
  • Most common in stomach and small bowel, followed by rectum

  • Leimyosarcoma
  • Melanoma

Epidemiology

Incidence

Common

  • 4th most common (3rd for each sex)
  • 42,000 cases annually (11%)
  • 75 and over, peak 85-89
  • Small decrease in incidence over last 10-years

Mortality + Survival

Mortality

  • 2nd commonest cause of cancer death
  • 3rd most common for each sex
  • Since 1970s decreased by 50% females, 41% males

Survival

  • 78% at one year
  • 58% at five years
  • 53% at ten years
  • Below the European average

Aetiology

  • Interplay of many factors
  • Majority sporadic
  • Age greatest risk factor

Aetiology

Genetic

  • Large number of mutations
  • Commonest:
  • APC (Tumour suppressor gene)
  • p53 (Tumour suppressor gene)
  • KRAS (Oncogene)
  • Mismatch repair (MMR)

Congenital

List some!

Congenital

2-5% of total Colorectal cancers

Family History

One 1st Deg. relative RR 2.24

Two 1st Deg. relatives RR 3.97

Hereditary Nonpolyposis (HNPCC)/ Lynch Syndrome

  • Autosomal dominant
  • Colorectal, Endometrial, Gastric, Ovarian
  • Amsterdam Criteria

Familial Adenomatous Polyposis

  • Autosomal dominant
  • Multiple benign polyps

Gardner's Syndrome

  • Subtype FAP
  • Osteomas, thyroid ca, epidermoid cysts, fibromas

Acquired

Epigenetic mutation more frequent

  • Reduction in enzyme repair expression
  • Age related
  • Chemotherapy sensitivity

IBD

  • Crohn's- 2% at 10 years, 8% at 20, 18% at 30
  • UC - 16% over 30 years

Environmental

List some!

Environmental

  • Age
  • Obesity - also worse outcomes
  • Smoking
  • Diet- poor fibre, red/processed meat
  • Poor physical activity
  • Alcohol
  • Previous Ca
  • Endocrine - Diabetes, acromegaly

Clinical Features

Asymptomatic Patient at Screening

Symptomatic in Community

Emergency Presentation

Symptoms

Early vs Late

Proximal vs Distal

Symptoms

List some!

Time

Anaemia (Up to 10% have CRC)

Change in bowel habit

PR bleeding

Pain

Weight loss

Distention

Vomiting

Location

Right Sided

  • Anaemia

Left Sided

  • Ribbon/loose stools
  • Obstruction

Rectal

  • Pain
  • PR bleeding
  • Tenesmus

Management

MDT Approach

  • Patient Specific
  • Disease Specific

Management

Investigations

Diagnostic vs Staging

Name some!

Investigations

Full History and Examination

  • Risk factors
  • Family History
  • PR exam

Diagnostic

Bloods

  • FBC, U+Es, LFTs
  • Carcinoembryonic Antigen (CEA)

Colonoscopy

  • Physiological burden
  • Operator dependent (6% miss rate)
  • Complications - sedation, perforation
  • Biopsy

CT Colon

  • Endoluminal view
  • Well tolerated

Barium Enema

  • Less used

Staging

CT Thorax, Abdomen and Pelvis

MRI Pelvis

PET Scan

Staging

Stage

Stage 1

  • Mucosa and submucosa involved. It has not spread to the lymph nodes.

Stage 2

  • 2A No lymph nodes or nearby tissue. Limited to muscularis propria,
  • 2B No lymph nodes, but visceral peritoneum involved.
  • 2C No lymph nodes, but it has grown to nearby organs or structures.

Stage 3

  • 3A One to three lymph nodes involved. No distant spread.
  • 3B One to three lymph nodes, visceral peritoneum or other organs or structures involved. Or four or more nearby lymph nodes but limited to bowel.
  • 3C Visceral peritoneum involved. Four or more nearby lymph nodes, but not distant sites.

Stage 4

  • 4A Spread to one distant site, such as the liver or lungs.
  • 4B Spread to two or more distant sites, such as the lungs and liver.

Grade

G1 - Well differentiated (Low grade)

G2 - Moderately differentiated (Intermediate grade)

G3 - Poorly differentiated (High grade)

G4 - Undifferentiated (High grade)

Grade

Treatment

Surgical Resection

  • Counselling, stoma care
  • Laparoscopic vs open

Systemic Therapy

  • FOLFOX
  • CapeOX

Colon

Stage 1-2

  • Resection
  • En bloc lymph node

Stage 3

  • Plus adjuvant chemo

Stage 4 resectable metastasis

  • Synchronous/staged resection
  • Pre/post-op adjuvant
  • Peritoneal disease

Stage 4 unresectable

  • Palliative

Rectal

Stage 1

  • Transanal procedures
  • Anterior resection

Stage 2 - 3

  • Pre-op chemoradiotherapy

Stage 4 resectable mets

  • Synchronous/staged resection
  • Pre/post-op adjuvant
  • Peritoneal disease treatment

Stage 4

  • Palliative

References

Questions?

https://www.nice.org.uk/

https://bestpractice.bmj.com/

www.cancerresearchuk.org

www.mayoclinic.org

www.cancercenter.com

www.pathologyoutlines.com

www.webpathology.com

Learn more about creating dynamic, engaging presentations with Prezi